Milton Keynes University Hospital NHS Foundation Trust

Specialist MDT: Oxford University Hospitals NHS Foundation Trust

View Provider Services

The following services are available at this hospital trust (updated 2021). Men diagnosed at this trust may be able to access additional services from other trusts within the specialist multidisciplinary team:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Whole body MRI
  • Treatment Facilities:
    • Chemotherapy
    • Joint specialist MDT clinic
    • Clinical trials unit
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services

Data Quality

For these results, data for England were provided for 1st April 2019 to 31st March 2020 from the Rapid Cancer Registration Dataset (RCRD), which is sourced mainly from the Cancer Services and Outcomes Dataset (COSD) containing proxy tumour registrations, as the standard Cancer Registration data were unavailable. More details can be found here. Please note: the data quality results were amended in May 2022.

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 214 1052
Performance Status recorded 99% 60%
TNM completed 75% 44%
Stage variable assigned 83% 53%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 563 34801
Percentage of men diagnosed with metastatic disease 12% 13%

Management

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on PSA and Gleason score in the Rapid Cancer Registration Dataset